A detailed history of Quent Capital, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Quent Capital, LLC holds 226 shares of RARE stock, worth $9,887. This represents 0.0% of its overall portfolio holdings.

Number of Shares
226
Previous 226 -0.0%
Holding current value
$9,887
Previous $9,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 08, 2024

BUY
$37.42 - $51.61 $523 - $722
14 Added 6.6%
226 $9,000
Q1 2024

May 02, 2024

BUY
$43.02 - $53.69 $3,312 - $4,134
77 Added 57.04%
212 $9,000
Q4 2023

Jun 14, 2024

SELL
$31.73 - $49.19 $1,713 - $2,656
-54 Reduced 28.57%
135 $6,000
Q4 2023

Jan 19, 2024

SELL
$31.73 - $49.19 $1,713 - $2,656
-54 Reduced 28.57%
135 $6,000
Q3 2023

Jun 14, 2024

SELL
$34.92 - $46.66 $1,641 - $2,193
-47 Reduced 19.92%
189 $6,000
Q3 2023

Oct 10, 2023

SELL
$34.92 - $46.66 $1,641 - $2,193
-47 Reduced 19.92%
189 $6,000
Q1 2023

Jun 14, 2024

BUY
$36.99 - $48.71 $887 - $1,169
24 Added 11.32%
236 $9,000
Q4 2022

Jan 19, 2023

BUY
$33.72 - $46.33 $7,957 - $10,933
236 New
236 $0

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.06B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.